Frontline therapy for multiple myeloma

Antonio Palumbo, MD, from the University of Turin, Turin, Italy provides advice on how to treat multiple myeloma (MM). For patients younger than 75, autologous transplantation remains the standard of care and Dr Palumbo also suggests a three-drug combination induction therapy. For patients who are not eligible for a transplant, the advice is also a three-drug combination, which includes proteasome inhibitors plus an alkylating agent or a proteasome inhibitor plus IMiDs. For frail patients who are not transplant eligible and also have co-morbidities, Dr Palumbo suggests a two-drug combination therapy.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.